Other Science
480 articles
Jennie Fortunoff
Jennie Fortunoff, President of Esterow Events & Consulting, Inc., a full-service event planning company based in New York, NY, is proud to serve on the board in honor of her late husband, Louis W. Fortunoff, who succumbed to pancreatic cancer at the young age of 47, in 2012. Jennie brings extensive experience to her new […]
Susan Randel
When a new story appears on the Let’s Win website, Susan Randel has had her hands on it. Susan writes some of the stories, edits the ones she doesn’t write, and posts them all, to keep the information on Let’s Win fresh and vital. With more than 35 years’ experience, she has worked as an […]
Surviving a Pancreatic Neuroendocrine Tumor
Lisa Beckendorf was suprised to find out that the cause of her digestive troubles was a pancreatic neuroendocrine tumor (PNET).
A Clinical Trial Gives Me Hope
When Dennis Rues’s pancreatic cancer recurred, his doctors recommended that he join a clinical trial. Now he’s doing well.
The Benefit of Multiple Clinical Trials
Dr. Ira Sharp knew that his best bet for surviving pancreatic cancer was to look for clinical trials as part of his treatment.
Could There Be a Cure in Vitamin C?
Vitamin C has been found to kill cancer cells that carry the KRAS mutation. This mutation is common in pancreatic and colorectal cancers.
Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.
Can a Pancreatic Cancer Screening Test Become a Reality?
Dr. Felice Schnoll-Sussman discusses screening options for pancreatic cancer and criteria for people who might want to get screened.
Stereotactic Body Radiation Therapy (SBRT) for Select Pancreatic Cancer Patients
Stereotactic body radiation therapy (SBRT) is increasingly being used to treat locally advanced pancreatic cancer, and make it surgically removable.
Targeted Therapy for Pancreatic Cancer
Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.
Most Cancer Mutations Are Random DNA Mistakes
In a large study, Dr. Bert Vogelstein of Johns Hopkins found that a majority of cancers, including pancreatic cancer, are caused by random mutations of DNA.
A Newly Identified Biomarker Panel Shows Promise in Earlier Pancreatic Cancer Detection
The first pancreatic cancer blood test may soon be a reality, as a biomarker panel from the lab of Dr. Ken Zaret shows promise in early testing.
A Simple Blood Test for Early Detection of Eight Cancers Shows Promise
Dr. Anne Marie Lennon explains the CancerSEEK blood test, a liquid biopsy in clinical trials for early detection of eight cancers, including pancreatic.
Man + Machine: Using Deep Learning for Early Detection of Pancreatic Cancer
Dr. Elliot Fishman is part of a team that is using artificial intelligence, or deep learning to develop techniques for early detection of pancreatic cancer.
Machine-Learning Assay May Improve Pancreatic Cyst Management
Dr. Anne Marie Lennon explains CompCyst, the artificial intelligence-based assay that can determine the best treatment for pancreatic cysts.